Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide Autogel for Inoperable Malignant Intestinal Obstruction
NCT02275338Phase 2Completed
- Sponsor
- Ipsen
- Start
- Nov 2014
- Primary completion
- Nov 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of lanreotide in intestinal obstruction, sponsored by Ipsen. Started Nov 2014; status: completed.
02
Drugs
lanreotide
03
Conditions
intestinal obstruction
Beyond the preview
Go deeper on NCT02275338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02275338.